FT3 (free triiodothyronine) and blood glucose are physiologically linked: thyroid hormones stimulate gluconeogenesis and glucose turnover, but in hyperthyroidism they can promote insulin resistance. Elevated FT3 with normal TSH may indicate subclinical hyperthyroidism, affecting fasting glucose and postprandial spikes. Conversely, low FT3 (hypothyroidism) reduces basal metabolic rate and alters insulin sensitivity. Direct-to-consumer tests often measure only TSH, not FT3 – a significant gap. If you self-monitor FT3 and blood glucose, watch for: 1) Fasting glucose ≥100 mg/dL or HbA1c ≥5.7% as warning signs. 2) FT3 outside the reference range (approx. 2.0–4.4 pg/mL) requires medical evaluation. 3) Genetic markers (e.g., APOA5 for triglycerides, PPARGC1A for mitochondrial function) have weak evidence for the FT3-glucose axis; clinical utility is low. Lifestyle factors (diet, exercise, sleep) and regular medical checkups are far more important. No DNA test can reliably predict thyroid or glucose disorders.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-ed0018ccfc1264b6ac254903